Ex vivo reversal of chemoresistance by tariquidar (XR9576).
Di Nicolantonio F, Knight LA, Glaysher S, Whitehouse PA, Mercer SJ, Sharma S, Mills L, Prin A, Johnson P, Charlton PA, Norris D, Cree IA.
Di Nicolantonio F, et al. Among authors: knight la.
Anticancer Drugs. 2004 Oct;15(9):861-9. doi: 10.1097/00001813-200410000-00006.
Anticancer Drugs. 2004.
PMID: 15457126